References
- Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of AF: the Task Force for the Management of AF of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369–2429. doi: 10.1093/eurheartj/ehq278.
- de Vos CB, Pisters R, Nieuwlaat R, et al. Progression from paroxysmal to persistent AF clinical correlates and prognosis. J Am Coll Cardiol. 2010;55:725–731. doi: 10.1016/j. jacc.2009.11.040.
- Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of AF developed in collaboration with EACTS. Eur Heart J. 2016;50:5:e1–e88. doi: 10.1093/ejcts/ezw313.
- Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic AF: the Framingham Heart Study. Circulation. 1994;89:724–730. doi: 10.1161/01.cir.89.2.724.
- Takemoto Y, Barnes ME, Seward JB, et al. Usefulness of left atrial volume in predicting first congestive heart failure in patients ≥65 years of age with well-preserved left ventricular systolic function. Am J Cardiol. 2005;96:832–836. doi: 10.1016/j.amjcard.2005.05.031.
- Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death: the Framingham Heart Study. Circulation. 1995;92:835–841.
- Su G, Cao H, Xu S, et al. Left Atrial Enlargement in the Early Stage of Hypertensive Heart Disease: A Common But Ignored Condition. The Journal of Clinical Hypertension. 2014;16:3:192-197. doi: 10.1111/jch.12282.
- Guglielmo M, Baggiano A, Muscogiuri G, et al. Multimodality imaging of left atrium in patients with AF. Journal of Cardiovascular Computed Tomography. 2019;6:340-346. doi: 10.1016/j.jcct.2019.03.005.
- Mahabadi AA, Samy B, Seneviratne SK, et al. Quantitative assessment of left atrial volume by electrocardiographic-gated contrast-enhanced multidetector computed tomography. J Cardiovasc Comput Tomogr. 2009;3:80–87. doi: 10.1016/j. jcct.2009.02.002.
- Christiaens L, Lequeux B, Ardilouze P, et al. A new method for measurement of left atrial volumes using 64-slice spiral computed tomography: comparison with two-dimensional echocardiographic techniques. Int J Cardiol. 2009;131:217–224. doi: 10.1016/j.ijcard.2007.10.020.
- Avelar E, Durst R, Rosito GA, et al. Comparison of the accuracy of multidetector computed tomography versus two-dimensional echocardiography to measure left atrial volume. Am J Cardiol. 2010;106:104–109. doi: 10.1016/j.amjcard.2010.02.021.
- Blum S, Meyre P, Aeschbacher S, Berger S, et al. Incidence and Predictors of AF Progression: A Systematic Review and Meta-Analysis. Heart Rhythm. 2018;16:4:502–510. doi: 10.1016/j. hrthm.2018.10.022.
- Nicolaou VN, Papadakis JE, Karatzis EN, et al. Impact of the metabolic syndrome on atrial size in patients with new-onset AF. Angiology. 2007;58:21–25. doi: 10.1177/0003319706297913.
- Ayer JG, Almafragy HS, Patel AA, et al. Body mass index is an independent determinant of left atrial size. Heart Lung Circ. 2008;17:19–24. doi: 10.1016/j.hlc.2007.04.006.
- Di Tullio MR, Sacco RL, Sciacca RR, Homma S. Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke. 1999;30:2019–2024. doi: 10.1161/01. str.30.10.2019.
- Lemire F, Tajik AJ, Hagler DJ. Asymmetric left atrial enlargement; an echocardiographic observation. Chest. 1976;69:779–781. doi: 10.1378/chest.69.6.779.
- Lester SJ, Ryan EW, Schiller NB, Foster E. Best method in clinical practice and in research studies to determine left atrial size. Am J Cardiol. 1999;84:829–832. doi: 10.1016/s0002-9149(99)00446-4.
- Russo C, Jin Z, Homma S, et al. Left atrial minimum volume and reservoir function as correlates of left ventricular diastolic function: impact of left ventricular systolic function. Heart. 2012;98:813–820. doi: 10.1136/heartjnl-2011-301388.
- Lee JS, Shim CY, Wi J, et al. Left ventricular diastolic function is closely associated with mechanical function of the left atrium in patients with paroxysmal AF. Circ J. 2013;77:697–704. doi: 10.1253/circj.cj-12-1009.
- Park SM, Park SW, Casaclang-Verzosa G, et al. Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy data from the Acorn trial. Am Heart J. 2009;157:762–710. doi: 10.1016/j.ahj.2008.12.018.
- Cheng YJ, Church TS, Kimball TE, et al. Comparison of coronary artery calcium detected by electron beam tomography in patients with to those without symptomatic coronary heart disease. Am J Cardiol. 2003;92:498–503. doi: 10.1016/s0002-9149(03)00714-8.
- Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E. Cardiac fibrosis in patients with AF: mechanisms and clinical implications. J Am Coll Cardiol. 2015;66:943–959. doi: 10.1016/j.jacc.2015.06.1313.
- O’Neal WT, Efird JT, Qureshi WT, et al. Coronary artery calcium progression and AF: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging. 2015;8:e003786. doi: 10.1161/CIRCIMAGING.115.003786.
- Pan NH, Tsao HM, Chang NC, Lee CM, Chen YJ, Chen SA. Dilated left atrium and pulmonary veins in patients with calcified coronary artery: a potential contributor to the genesis of AF. J Cardiovasc Electrophysiol. 2009;20:153–158. doi: 10.1111/j.1540-8167.2008.01290.x.
- Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during AF. Cardiovasc Res. 2002;54:230–246. doi: 10.1016/s0008-6363(02)00258-4.
- Avitall B, Bi J, Mykytsey A, Chicos A. Atrial and ventricular fibrosis induced by AF: evidence to support early rhythm control. Heart Rhythm. 2008;5:839–845. doi: 10.1016/j. hrthm.2008.02.042.
- Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of AF. Nat Rev Cardiol. 2015;12:230–243. doi: 10.1038/nrcardio.2015.2.
- O’Neill MD, Jaïs P, Takahashi Y, et al. The stepwise ablation approach for chronic AF--evidence for a cumulative effect. J Interv Card Electrophysiol. 2006;16:153–167. doi: 10.1007/s10840-006-9045-1.
- Blîndu E, Korodi S, Bordi L, Kovács I, Benedek I. Epicardial Fat Volume as a New Imaging-Based Feature Associated with Risk of Recurrence after Pulmonary Veins Ablation in AF. Journal of Interdisciplinary Medicine. 2020;5:2:64–70. doi: 10.2478/jim-2020-0012.
- Waldo AL, Becker RC, Tapson VF, Colgan KJ. Hospitalized patients with AF and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol. 2005;46:1729–1736. doi: 10.1016/j.jacc.2005.06.077.
- Andersson T, Magnuson A, Bryngelsson IL, et al. All-cause mortality in 272,186 patients hospitalized with incident AF 1995-2008: a Swedish nationwide long-term case-control study. Eur Heart J. 2013;34:1061–1067. doi: 10.1093/eurheartj/ehs469.
- Chen SC, Chang JM, Tsai YC, et al. Left atrial diameter and albumin with renal outcomes in chronic kidney disease. Int J Med Sci. 2013;10:575–584. doi: 10.7150/ijms.5845.
- Santhanakrishnan R, Wang N, Larson MG, et al. AF begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation. 2016;133:484–492. doi: 10.1161/CIRCULATIONAHA.115.018614.
- Pappone C, Augello G, Sala S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal AF: the APAF study. J Am Coll Cardiol. 2006;48:2340–2347. doi: 10.1016/j. jacc.2006.08.037.
- Jaïs P, Cauchemez B, Macle L, et al. Catheter ablation versus antiarrhythmic drugs for AF: the A4 study. Circulation. 2008;118:2498–2505. doi: 10.1161/CIRCULATIONAHA.108.772582.
- Wilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal AF: a randomized controlled trial. JAMA. 2010;303:333–340. doi: 10.1001/jama.2009.2029.
- Marrouche NF, Brachmann J, Andresen D, Siebels et al. CASTLE-AF Investigators. Catheter ablation for AF with heart failure. N Engl J Med. 2018;378:417–427. doi: 10.1056/NEJMoa1707855.
- Jones DG, Haldar SK, Hussain W, et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent AF in heart failure. J Am Coll Cardiol. 2013;61:1894–1903. doi: 10.1016/j.jacc.2013.01.069.
- Hunter RJ, Berriman TJ, Diab I, et al. A randomized controlled trial of catheter ablation versus medical treatment of AF in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol. 2014;7:31–38. doi: 10.1161/CIRCEP.113.000806.
- Siontis KC, Noseworthy PA. FIRE or ICE for paroxysmal AF?—perspectives from the largest randomized evaluation of cryoballoon and radiofrequency ablation to date. J Thorac Dis. 2017;9:3:419-422. doi: 10.21037/jtd.2017.02.93.